Genome-wide detection of LOH in prostate cancer using human SNP microarray technology

Genomics

Volumn 81, Issue 3, 2003, Pages 260-269

  Dumur, Catherine I ^a   Dechsukhum, Chavaboon ^a   Ware, Joy L ^a   Cofield, Stacey S ^a   Best, Al M ^a   Wilkinson, David S ^a   Garrett, Carleton T ^a   Ferreira Gonzalez, Andrea ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Genome wide; LOH; Oligonucleotide microarray; Prostate cancer; SNP

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; GENE MAPPING; GENOME; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0037345361     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0888-7543(03)00020-X     Document Type: Article

References (45)

1. Brown M.A. Tumor suppressor genes and human cancer. Adv. Genet. 36:1997;45-135.
2. Nupponen N., Visakorpi T. Molecular cytogenetics of prostate cancer. Microsc. Res. Tech. 51:2000;456-463.
3. Dahiya R., et al. Chromosome 3p24-26 and 3p22-12 loss in human prostatic adenocarcinoma. Int. J. Cancer. 1:1997;20-25.
4. Verma R.S., Manikal M., Conte R.A., Godec C.J. Chromosomal basis of adenocarcinoma of the prostate. Cancer Invest. 17:1999;441-447.
5. Prasad M.A., Trybus T.M., Wojno K.J., Macoska J.A. Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers identification of a potential tumor suppressor gene site . Genes Chromosomes Cancer. 23:1998;255-262.
6. Dahiya R., et al. Deletion of chromosome 11p15, p12, q22, q23-24 loci in human prostate cancer. Int. J. Cancer. 72:1997;283-288.
7. Elo J.P., et al. Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer. Cancer Res. 57:1997;3356-3359.
8. Padalecki S.S., et al. Identification of two distinct regions of allelic imbalance on chromosome 18Q in metastatic prostate cancer. Int. J. Cancer. 85:2000;654-658.
9. B. Watson, The dysregulation of JUNB gene expression in human prostate cancer cell lines. Ph.D. thesis at Virginia Commonwealth University (2000).
10. Bae V.L., et al. Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line. Prostate. 34:1998;275-282.
11. Dreijerink K., et al. The candidate tumor suppressor gene, RASSFIA, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc. Natl. Acad. Sci. USA. 98:2001;7504-7509.
12. Agathanggelou A., et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene. 20:2001;1509-1518.
13. Martinez A., et al. Chromosome 3p allele loss in early invasive breast cancer detailed mapping and association with clinicopathological features . Mol. Pathol. 54:2001;300-306.
14. Fullwood P., et al. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. Cancer Res. 59:1999;4662-4667.
15. Kuramochi M., et al. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat. Genet. 27:2001;427-430.
16. Baysal B.E., et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 287:2000;848-851.
17. Bharaj B.B., Luo L.Y., Jung K., Stephan C., Diamandis E.P. Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers. Prostate. 51:2002;35-41.
18. Luo L.Y., Rajpert-De Meyts E.R., Jung K., Diamandis E.P. Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue. Br. J. Cancer. 85:2001;220-224.
19. Sasaki T., et al. Assignment of the human beta-microseminoprotein gene (MSMB) to chromosome 10q11.2. Cytogenet. Cell. Genet. 72:1996;177-178.
20. Srivastava M., et al. ANX7, a candidate tumor suppressor gene for prostate cancer. Proc. Natl. Acad. Sci. U S A. 98:2001;4575-4580.
21. Paris P.L., et al. Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus. Cancer Res. 60:2000;3645-3649.
22. Paige A.J., et al. A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D. Cancer Res. 60:2000;1690-1697.
23. Paige A.J., et al. WWOX a candidate tumor suppressor gene involved in multiple tumor types . Proc. Natl. Acad. Sci. USA. 98:2001;11417-11422.
24. Lee H.Y., Lee H. Inhibitory activity of nm23-H1 on invasion and colonization of human prostate carcinoma cells is not mediated by its NDP kinase activity. Cancer Lett. 145:1999;93-99.
25. Langbein S., et al. Alteration of the LRP1B gene region is associated with high grade of urothelial cancer. Lab. Invest. 82:2002;639-643.
26. Hyytinen E.R., et al. Defining the region(s) of deletion at 6q16-q22 in human prostate cancer. Genes Chromosomes Cancer. 34:2002;306-312.
27. Sato K., et al. Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma. J. Natl. Cancer Inst. 91:1999;1574-1580.
28. Haggman M.J., Wojno K.J., Pearsall C.P., Macoska J.A. Allelic loss of 8p sequences in prostatic intraepithelial neoplasia and carcinoma. Urology. 50:1997;643-647.
29. Perinchery G., et al. High frequency of deletion on chromosome 9p21 may harbor several tumor-suppressor genes in human prostate cancer. Int. J. Cancer. 83:1999;610-614.
30. Fiedler U., et al. LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13. Anticancer Res. 21:2001;2341-2350.
31. Bae V.L., Jackson-Cook C.K., Brothman A.R., Maygarden S.J., Ware J.L. Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells association with decreased epidermal growth factor receptor (EGFR) expression . Int. J. Cancer. 58:1994;721-729.
32. Lindblad-Toh K., et al. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nat. Biotechnol. 18:2000;1001-1005.
33. Cyr L., Francis K. Measures of clinical agreement for nominal and categorical data the kappa coefficient . Comput. Biol. Med. 22:1992;239-246.
34. Luo R.Z., et al. Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI. Biochim. Biophys. Acta. 1519:2001;216-222.
35. Bluteau O., et al. Specific association between alcohol intake, high grade of differentiation and 4q34-q35 deletions in hepatocellular carcinomas identified by high resolution allelotyping. Oncogene. 21:2002;1225-1232.
36. Achille A., et al. Chromosome 5 allelic losses are early events in tumours of the papilla of Vater and occur at sites similar to those of gastric cancer. Br. J. Cancer. 78:1998;1653-1660.
37. Lassus H., et al. Comparison of serous and mucinous ovarian carcinomas distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4 . Lab. Invest. 81:2001;517-526.
38. Hatta Y., Takeuchi S., Yokota J., Koeffler H.P. Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12.3-13.1 (region of TEL and Kip1 loci) and chromosome 12q23-ter evidence for two new tumour-suppressor genes . Br. J. Cancer. 75:1997;1256-1262.
39. Zweemer R.P., et al. Comparative genomic hybridization of microdissected familial ovarian carcinoma two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma . Lab. Invest. 81:2001;1363-1370.
40. Zhao X., et al. A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma. Cancer Res. 61:2001;7383-7387.
41. Hoff C., et al. Physical and transcriptional mapping of the 17p13.3 region that is frequently deleted in human cancer. Genomics. 70:2000;26-33.
42. Vermeulen S., et al. Regulation of the invasion suppressor function of the cadherin/catenin complex. Pathol. Res. Pract. 192:1996;694-707.
43. Yamamoto N., et al. Frequent allelic loss/imbalance on the long arm of chromosome 21 in oral cancer evidence for three discrete tumor suppressor gene loci . Oncol. Rep. 6:1999;1223-1227.
44. Ohgaki K., et al. Mapping of a new target region of allelic loss to a 6-cM interval at 21q21 in primary breast cancers. Genes Chromosomes Cancer. 23:1998;244-247.
45. Petersen S., et al. Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Br. J. Cancer. 82:2000;65-73.